Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12,438 GBX | -0.58% |
|
-1.13% | +17.53% |
01:21pm | AstraZeneca Says FDA Approves Imfinzi to Treat Endometrial Cancer | MT |
10:48am | AstraZeneca: positive phase 3 results in lymphoma | CF |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+17.53% | 246B | |
+50.70% | 791B | |
+41.67% | 630B | |
+18.77% | 328B | |
+8.79% | 298B | |
+0.12% | 225B | |
+10.00% | 218B | |
+3.68% | 160B | |
-4.38% | 156B | |
-3.02% | 116B |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC
- ASTRAZENECA : Gets a Neutral rating from UBS